Ustekinumab Dose Based on BSA and Body Weight: Clinical Trials

1 trial of Ustekinumab Dose Based on BSA and Body Weight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Ustekinumab Dose Based on BSA and Body Weight: new trials by email Literature Review of Ustekinumab Dose Based on BSA and Body Weight trials Research Report on Ustekinumab Dose Based on BSA and Body Weight

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo - Colitis, Ulcerative
Phase 3CompletedJanssen Research & Development, LLC1122021-03-172026-10-20

Conditions studied

Colitis, Ulcerative (1)

Sponsors

Janssen Research & Development, LLC (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Japan (1)  ·  Poland (1)  ·  Russia (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2019 (1), 2023 (1)